Jihyeon Yoon

Gwangju, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Design, Synthesis and Biological Evaluation of Pyrazolopyrimidine Derivatives as Aryl Hydrocarbon Receptor Antagonists for Colorectal Cancer Immunotherapy.

Design, Synthesis and Biological Evaluation of Pyrazolopyrimidine Derivatives as Aryl Hydrocarbon Receptor Antagonists for Colorectal Cancer Immunotherapy.

Journal: Pharmaceutics

Published: September 10, 2025

Synthesis and Biological Evaluation of Peripheral 5HT2B Antagonists for Liver Fibrosis.

Synthesis and Biological Evaluation of Peripheral 5HT2B Antagonists for Liver Fibrosis.

Journal: Journal of medicinal chemistry

Published: March 06, 2025

Synthesis and Biological Evaluation of Peripheral HTR2A Antagonists for Colorectal Cancer.

Synthesis and Biological Evaluation of Peripheral HTR2A Antagonists for Colorectal Cancer.

Journal: Journal of medicinal chemistry

Published: January 06, 2025

Discovery of novel arylpyridine derivatives for motile ciliogenesis.

Discovery of novel arylpyridine derivatives for motile ciliogenesis.

Journal: European journal of medicinal chemistry

Published: February 19, 2024

Synthesis and biological evaluation of xanthine derivatives with phenacyl group as tryptophan hydroxylase 1 (TPH1) inhibitors for obesity and fatty liver disease.

Synthesis and biological evaluation of xanthine derivatives with phenacyl group as tryptophan hydroxylase 1 (TPH1) inhibitors for obesity and fatty liver disease.

Journal: Bioorganic & medicinal chemistry letters

Published: June 10, 2023

Discovery of a peripheral 5HT2A antagonist as a clinical candidate for metabolic dysfunction-associated steatohepatitis.

Discovery of a peripheral 5HT2A antagonist as a clinical candidate for metabolic dysfunction-associated steatohepatitis.

Journal: Nature communications

Published: February 26, 2023

Identification of New Non-BBB Permeable Tryptophan Hydroxylase Inhibitors for Treating Obesity and Fatty Liver Disease.

Identification of New Non-BBB Permeable Tryptophan Hydroxylase Inhibitors for Treating Obesity and Fatty Liver Disease.

Journal: Molecules (Basel, Switzerland)

Published: March 31, 2022

Synthesis and biological evaluation of tyrosine derivatives as peripheral 5HT2A receptor antagonists for nonalcoholic fatty liver disease.

Synthesis and biological evaluation of tyrosine derivatives as peripheral 5HT2A receptor antagonists for nonalcoholic fatty liver disease.

Journal: European journal of medicinal chemistry

Published: January 13, 2022

Peripheral Selective Oxadiazolylphenyl Alanine Derivatives as Tryptophan Hydroxylase 1 Inhibitors for Obesity and Fatty Liver Disease.

Peripheral Selective Oxadiazolylphenyl Alanine Derivatives as Tryptophan Hydroxylase 1 Inhibitors for Obesity and Fatty Liver Disease.

Journal: Journal of medicinal chemistry

Published: January 08, 2021

Design, Synthesis, and Biological Evaluation of New Peripheral 5HT2A Antagonists for Nonalcoholic Fatty Liver Disease.

Design, Synthesis, and Biological Evaluation of New Peripheral 5HT2A Antagonists for Nonalcoholic Fatty Liver Disease.

Journal: Journal of medicinal chemistry

Published: April 15, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026